Discover why TSMC's stock has outperformed the market due to AI-driven growth, but faces challenges from geopolitical risks.

A review of BB Biotech’s portfolio and results for 2024 as well as the outlook for 2025 will be included in the Annual Report, to be published on February 21, 2025. The figures and information ...

Partaking in this year’s conference has been a rejuvenating respite from my customary endeavours, yet it has ignited in me a ...

Following the annual meeting of the Rogers International Commodity Index (RICI®) Committee, Jim Rogers and Beeland Interests, Inc. announce no adjustments to the weights or components comprising the ...

BB Biotech AG reports preliminary full-year 2024 results with a net profit of CHF 76 mn, proposing a dividend of CHF 1.80 per share at the AGM on March 19, 2025, focusing on shareholder returns and bi ...